Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ultra Nasdaq Biotechnology 2X ETF (BIB)

Ultra Nasdaq Biotechnology 2X ETF (BIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Proshare Advisors LLC
  • Assets Under Management 89,276,300
  • Shares Outstanding, K 1,050
  • 60-Month Beta 1.38
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.62 (0.73%)
  • Most Recent Dividend 0.135 on 12/24/25
  • Management Fee 0.95%

Options Overview Details

View History
  • Implied Volatility 51.96% (-2.18%)
  • Historical Volatility 39.05%
  • IV Percentile 78%
  • IV Rank 32.51%
  • IV High 85.88% on 04/08/25
  • IV Low 35.62% on 03/24/25
  • Expected Move (DTE 9) 7.00 (8.23%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 6
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 320
  • Open Int (30-Day) 346
  • Expected Range 78.03 to 92.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.70 +8.04%
on 03/06/26
90.90 -6.47%
on 02/25/26
+0.90 (+1.07%)
since 02/10/26
3-Month
75.62 +12.44%
on 01/05/26
90.90 -6.47%
on 02/25/26
+5.59 (+7.04%)
since 12/10/25
52-Week
33.78 +151.70%
on 04/09/25
90.90 -6.47%
on 02/25/26
+30.96 (+57.25%)
since 03/10/25

Most Recent Stories

More News
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue effort....

VHT : 283.48 (-0.64%)
ME : 0.6063 (-21.26%)
VTI : 333.51 (-0.23%)
BIB : 85.03 (+1.34%)
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility

Short interest in the stock has grown steadily since mid-December, rising from 0.9% to 8.5% by the end of January, according to Koyfin data.

TNXP : 14.17 (+1.65%)
VXF : 210.38 (-0.39%)
VTI : 333.51 (-0.23%)
BIB : 85.03 (+1.34%)
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding

Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.

PSIL : 17.83 (+0.98%)
VXF : 210.38 (-0.39%)
NRXP : 1.8100 (+4.62%)
BIB : 85.03 (+1.34%)
BeiGene Stock Eyes 2-Week High After EU Approves Cancer Treatment: Retail Enthusiasm Grows

The latest approval adds to BeiGene’s momentum, marking six EU indications granted in just over a year.

BGNE : 184.71 (+0.49%)
FBT : 199.69 (-1.09%)
BIB : 85.03 (+1.34%)
QQQJ : 37.17 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Fund Summary

The ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the NASDAQ Biotechnology Index.

See More

Key Turning Points

3rd Resistance Point 89.54
2nd Resistance Point 88.14
1st Resistance Point 86.58
Last Price 85.03
1st Support Level 83.63
2nd Support Level 82.24
3rd Support Level 80.68

See More

52-Week High 90.90
Last Price 85.03
Fibonacci 61.8% 69.08
Fibonacci 50% 62.34
Fibonacci 38.2% 55.60
52-Week Low 33.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar